tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Holding XLO?
Track your performance easily

Xilio Therapeutics (XLO) Financial Statements

119 Followers

Xilio Therapeutics Financial Overview

Xilio Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.719; its P/E ratio is ―; Xilio Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.26M$ 2.36M---
Gross Profit$ 2.26M$ 2.36M---
EBIT$ -14.02M$ -13.93M$ -17.20M$ -17.65M$ -17.36M
EBITDA$ -13.64M$ -13.48M$ -16.76M$ -17.20M$ -16.90M
Net Income Common Stockholders$ -14.02M$ -13.93M$ -17.20M$ -17.65M$ -16.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 61.30M$ 74.90M$ 34.00M$ 44.70M$ 59.80M
Total Assets$ 74.66M$ 89.87M$ 82.61M$ 60.93M$ 77.84M
Total Debt$ 8.41M$ 8.68M$ 8.94M$ 12.50M$ 14.39M
Net Debt$ -52.88M$ -66.22M$ -25.06M$ -32.20M$ -45.41M
Total Liabilities$ 53.68M$ 56.46M$ 56.84M$ 24.10M$ 25.34M
Stockholders Equity$ 20.97M$ 33.46M$ 25.77M$ 36.83M$ 52.50M
Cash Flow-
Free Cash Flow$ -13.68M$ 19.93M$ -10.50M$ -13.43M$ -13.37M
Operating Cash Flow$ -13.67M$ 19.95M$ -10.50M$ -13.43M$ -13.37M
Investing Cash Flow$ -9.00K$ -21.00K---
Financing Cash Flow$ -3.00K$ 20.04M$ 954.00K$ -1.63M$ -2.24M
Currency in USD

Xilio Therapeutics Earnings and Revenue History

Xilio Therapeutics Debt to Assets

Xilio Therapeutics Cash Flow

Xilio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis